G Loewenbaum - Luminex Insider

Luminex Corporation -- USA Stock  

USD 20.64  0.08  0.39%

Independent Chairman of the Board

Mr. G. Walter Loewenbaum II is an Independent Chairman of the Board of Luminex Corporationration since September 2002. He served as Vice Chairman of the Board of Directors from April 1998 until January 2000. Mr. Loewenbaum also has served as chairman of the board of directors of 3D Systems since September 1999 and was previously chairman of the board of directors of Envoy. He holds a B.A. from the University of North Carolina. Mr. Loewenbaum became involved with Luminex as an original investor in Luminex prior to our initial public offering. As an investment banker and private equity investor Mr. Loewenbaum has worked with multiple companies in a variety of different industries at different phases of organizational development ranging from startup to publicly traded. He brings depth of knowledge in serving as chairman for public and private companies building stockholder value and capital market considerations
Age: 69  Chairman Since 2002      
512-219-8020  www.luminexcorp.com
Loewenbaum also provides continuity to the Board of Directors, given his service on the Board since Luminex earliest years of operation.

G Loewenbaum Latest Insider Activity

G Loewenbaum over a week ago via Macroaxis 
Luminex exotic insider transaction detected
G Loewenbaum over a week ago via Macroaxis 
3D Systems exotic insider transaction detected
G Loewenbaum over two weeks ago via Macroaxis 
3D Systems exotic insider transaction detected
G Loewenbaum over two weeks ago via Macroaxis 
Luminex exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 4.0 % which means that it generated profit of $4.0 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 6.9 % meaning that it created $6.9 on every $100 dollars invested by stockholders.

Similar Executives

Found 3 records

CHAIRMAN Since

Erez RaphaelDarioHealth Corp
2014
Michael MussallemEdwards Lifesciences Corporatio
2000
Jeffrey EberweinDigirad Corporation
2013

Entity Summary

Luminex Corporationration develops, manufactures, and sells proprietary biological testing technologies and solutions for the diagnostics, pharmaceutical, and life sciences industries worldwide. Luminex Corporation (LMNX) is traded on NASDAQ in USA. It is located in TEXAS, U.S.A and employs 806 people. Luminex is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Performance Analysis Now
   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
Hide  View All  NextLaunch Performance Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Luminex Corporation to your portfolio

Top Management

Luminex Leadership Team
Nachum Shamir, CEO
Jim Kever, Director
Thomas Erickson, Director, MBA
Nancy Fairchild, President
Jay Johnston, Director, MBA
Todd Bennett, President
Tadd Lazarus, President
G Loewenbaum, Chairman
Walter Loewenbaum, Chairman
Edward Ogunro, Director, Ph.D
Randall Myers, President
Kevin McNamara, Director, MBA
Robert Cresci, Director, MBA
Fred Goad, Director
Richard Rew, President
Russell Bradley, SVP
Stephen Eck, Director, Ph.D
Harriss Currie, CFO, MBA
Jimmy Kever, Director
Matthew Scalo, Director

Stock Performance

Luminex Performance Indicators